Insider · CIK 0001866239
Eric Siemers
Files at ABOS (Acumen Pharmaceuticals, Inc.). First filing Jan 7, 2025, latest Jan 23, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
ABOS: Acumen Pharmaceuticals, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 10Weak | Acumen Pharmaceuticals, Inc. | $5,118 3,219 shares | -2% | - | |
| 10Weak | Acumen Pharmaceuticals, Inc. | $20k 10,859 shares | -9% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 21, 2025 | ABOS Acumen Pharmaceuticals, Inc. | SOpen-market sale Common Stock10b5-1 | -3,219 | $1.59 | $5,118 | 170,298 | Jan 23, 2025 |
| Jan 3, 2025 | ABOS Acumen Pharmaceuticals, Inc. | SOpen-market sale Common Stock10b5-1 | -10,859 | $1.85 | $20k | 106,717 | Jan 7, 2025 |
| Jan 6, 2025 | ABOS Acumen Pharmaceuticals, Inc. | AGrant or award Common Stock10b5-1 | +66,800 | $0.00 | $0 | 173,517 | Jan 7, 2025 |
| Jan 6, 2025 | ABOS Acumen Pharmaceuticals, Inc. | AGrant or award Employee Stock Option (right to buy)derivative10b5-1 | +100,300 | $0.00 | $0 | 100,300 | Jan 7, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.